Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Harvard Business School
Express Scripts
Dow
Johnson and Johnson

Last Updated: May 21, 2022

CLINICAL TRIALS PROFILE FOR ZYPREXA


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Zyprexa

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000374 ↗ Treatment for First-Episode Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 4 1998-09-01 This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
NCT00000374 ↗ Treatment for First-Episode Schizophrenia Completed The Zucker Hillside Hospital Phase 4 1998-09-01 This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
NCT00000374 ↗ Treatment for First-Episode Schizophrenia Completed Northwell Health Phase 4 1998-09-01 This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Zyprexa

Condition Name

Condition Name for Zyprexa
Intervention Trials
Schizophrenia 49
Schizoaffective Disorder 15
Bipolar Disorder 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Zyprexa
Intervention Trials
Schizophrenia 51
Psychotic Disorders 22
Bipolar Disorder 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zyprexa

Trials by Country

Trials by Country for Zyprexa
Location Trials
United States 235
Canada 20
Spain 7
Russian Federation 6
China 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Zyprexa
Location Trials
New York 27
California 18
Pennsylvania 13
Ohio 12
Massachusetts 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zyprexa

Clinical Trial Phase

Clinical Trial Phase for Zyprexa
Clinical Trial Phase Trials
Phase 4 39
Phase 3 28
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Zyprexa
Clinical Trial Phase Trials
Completed 93
Terminated 16
Recruiting 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zyprexa

Sponsor Name

Sponsor Name for Zyprexa
Sponsor Trials
Eli Lilly and Company 30
National Institute of Mental Health (NIMH) 17
Dr. Reddy's Laboratories Limited 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Zyprexa
Sponsor Trials
Other 126
Industry 67
NIH 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Medtronic
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.